Tweet
Syndicated from In Sequence RSS Feed
During a joint conference call last week, Invitrogen and ABI executives disclosed, for the first time, that Invitrogen has been working internally on a “third-generation” sequencing system, and stressed how the companies could improve front-end workflows and optimize reagents for ABI’s SOLiD sequencing system.
More...
During a joint conference call last week, Invitrogen and ABI executives disclosed, for the first time, that Invitrogen has been working internally on a “third-generation” sequencing system, and stressed how the companies could improve front-end workflows and optimize reagents for ABI’s SOLiD sequencing system.
More...